Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders
P. Jeffrey Conn, Craig W. Lindsley, Jens Meiler, et al.
Nature Reviews Drug Discovery (2014) Vol. 13, Iss. 9, pp. 692-708
Open Access | Times Cited: 239

Showing 1-25 of 239 citing articles:

Current Concepts and Treatments of Schizophrenia
Piotr Stępnicki, Magda Kondej, Agnieszka A. Kaczor
Molecules (2018) Vol. 23, Iss. 8, pp. 2087-2087
Open Access | Times Cited: 460
Complex Pharmacology of Free Fatty Acid Receptors
Graeme Milligan, Bharat Shimpukade, Trond Ulven, et al.
Chemical Reviews (2016) Vol. 117, Iss. 1, pp. 67-110
Open Access | Times Cited: 247
Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders
Daniel J. Foster, P. Jeffrey Conn
Neuron (2017) Vol. 94, Iss. 3, pp. 431-446
Open Access | Times Cited: 218
GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures
Ichio Shimada, Takumi Ueda, Yutaka Kofuku, et al.
Nature Reviews Drug Discovery (2018) Vol. 18, Iss. 1, pp. 59-82
Open Access | Times Cited: 217
Novel Allosteric Modulators of G Protein-coupled Receptors
Patrick R. Gentry, Patrick M. Sexton, Arthur Christopoulos
Journal of Biological Chemistry (2015) Vol. 290, Iss. 32, pp. 19478-19488
Open Access | Times Cited: 188
Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery
Lauren M. Slosky, Marc G. Caron, Lawrence S Barak
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 4, pp. 283-299
Open Access | Times Cited: 136
Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors
Craig W. Lindsley, Kyle A. Emmitte, Corey R. Hopkins, et al.
Chemical Reviews (2016) Vol. 116, Iss. 11, pp. 6707-6741
Open Access | Times Cited: 166
New paradigms in GPCR drug discovery
Kenneth A. Jacobson
Biochemical Pharmacology (2015) Vol. 98, Iss. 4, pp. 541-555
Open Access | Times Cited: 163
Endogenous Allosteric Modulators of G Protein–Coupled Receptors
Emma T. van der Westhuizen, Céline Valant, Patrick M. Sexton, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 353, Iss. 2, pp. 246-260
Open Access | Times Cited: 137
Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice
Cinzia Vicidomini, Luisa Ponzoni, Dmitry Lim, et al.
Molecular Psychiatry (2016) Vol. 22, Iss. 5, pp. 689-702
Open Access | Times Cited: 134
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts
Eric A. Wold, Jianping Chen, Kathryn A. Cunningham, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 1, pp. 88-127
Open Access | Times Cited: 132
Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders
Mark J. Millan, Guy M. Goodwin, Andreas Meyer‐Lindenberg, et al.
European Neuropsychopharmacology (2015) Vol. 25, Iss. 5, pp. 599-656
Closed Access | Times Cited: 125
Biased mGlu 5 -Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu 5 Modulation of NMDAR Currents
Jerri M. Rook, Zixiu Xiang, Xiaohui Lv, et al.
Neuron (2015) Vol. 86, Iss. 4, pp. 1029-1040
Open Access | Times Cited: 123
Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases
Joana Duarte‐Neves, Luís Pereira de Almeida, Cláudia Cavadas
Neurobiology of Disease (2016) Vol. 95, pp. 210-224
Closed Access | Times Cited: 110
Exploring the Binding Mechanism of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators in Clinical Trials by Molecular Dynamics Simulations
Tingting Fu, Guoxun Zheng, Gao Tu, et al.
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 6, pp. 1492-1502
Closed Access | Times Cited: 110
Regulator of G-protein signaling (RGS) proteins as drug targets: Progress and future potentials
Joseph B. O’Brien, Joshua Wilkinson, David L. Roman
Journal of Biological Chemistry (2019) Vol. 294, Iss. 49, pp. 18571-18585
Open Access | Times Cited: 108
Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor
Robert B. Laprairie, Pushkar M. Kulkarni, Jeffrey R. Deschamps, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 6, pp. 1188-1203
Closed Access | Times Cited: 97
Ghrelin: From a gut hormone to a potential therapeutic target for alcohol use disorder
Mehdi Farokhnia, Monica L. Faulkner, Daria Piacentino, et al.
Physiology & Behavior (2019) Vol. 204, pp. 49-57
Closed Access | Times Cited: 97
Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction
Adam G. Walker, Cody J. Wenthur, Zixiu Xiang, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 4, pp. 1196-1201
Open Access | Times Cited: 94
G Protein-Coupled Receptors (GPCRs) in Alzheimer’s Disease: A Focus on BACE1 Related GPCRs
Juan Zhao, Yulin Deng, Zhaotan Jiang, et al.
Frontiers in Aging Neuroscience (2016) Vol. 8
Open Access | Times Cited: 89
The GABAB Receptor—Structure, Ligand Binding and Drug Development
Linn Samira Mari Evenseth, Mari Gabrielsen, Ingebrigt Sylte
Molecules (2020) Vol. 25, Iss. 13, pp. 3093-3093
Open Access | Times Cited: 88
Structure-Based Optimization Strategies for G Protein-Coupled Receptor (GPCR) Allosteric Modulators: A Case Study from Analyses of New Metabotropic Glutamate Receptor 5 (mGlu5) X-ray Structures
J.A. Christopher, Zoltán Orgován, Miles Congreve, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 1, pp. 207-222
Closed Access | Times Cited: 87
A Genetically Encoded F-19 NMR Probe Reveals the Allosteric Modulation Mechanism of Cannabinoid Receptor 1
Xiaoyan Wang, Dongsheng Liu, Ling Shen, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 40, pp. 16320-16325
Closed Access | Times Cited: 65
Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs
Ruth Nussinov, Mingzhen Zhang, Ryan Maloney, et al.
Journal of Molecular Biology (2022) Vol. 434, Iss. 17, pp. 167569-167569
Open Access | Times Cited: 44
The pyridazine heterocycle in molecular recognition and drug discovery
Nicholas A. Meanwell
Medicinal Chemistry Research (2023) Vol. 32, Iss. 9, pp. 1853-1921
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top